drugset / Trial / NCT00909610
Ursodiol Tablets 500 mg Under Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to evaluate the comparative bioavailability between Ursodiol 500 mg Tablets (test) and Urso Forte™ 500 mg Tablets (reference) after a single-dose in healthy subjects under fasting conditions.
Timeline
- Start
- 2006-12
- Primary completion
- 2007-01
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ursodeoxycholic Acid | Small molecule | 500 mg | — |
Indications
No indication recorded.